The effect of long-term treatment with hypotensive drugs on blood viscosity and erythrocyte deformability in patients with essential arterial hypertension

Clinical Hemorheology and Microcirculation

Volumn 17, Issue 3, 1997, Pages 193-198

  Martinez M ^a  

^a Department of Clinical Pathology ^*  (Spain)

Author keywords

Hemorheology; Hypertension; Pharmacological treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CONTROLLED STUDY; ERYTHROCYTE DEFORMABILITY; ESSENTIAL HYPERTENSION; FEMALE; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD VISCOSITY; CALCIUM CHANNEL BLOCKERS; ERYTHROCYTE DEFORMABILITY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0030868310     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. S. Chien, R.G. King, G.B. Schuessler, R. Skalak, A. Tozeren, S. Usami and A.L. Copley, Roles of red cell deformability and aggregation in blood viscosity, Biorheology, AICHE Symposium Series 182 74 (1978), 161.
2. T.C. Chou, K.W. Lee and Y.A. Ding, Effect of felodipine-ER on blood pressure, platelet function, and Theological properties in hypertension, Can. J. Cardiol 9 (1993), 423-427.
3. R.B. Devereux et al., Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension, Am. J. Cardiol. 54 (1984), 592-595.
4. Y.A. Ding, T.C. Chou and K.C. Lin, Effects of long-acting propanolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension, J. Hum. Hypertens. 8 (1994), 273-278.
5. A.M. Ehrly, Drugs that alter blood viscosity: their role in therapy, Drugs 39 (1990), 155-159.
6. M. Hanss, Erythrocyte filterability measurement by initial flow rate method, Biorheology 20 (1983), 199-211.
7. H. Kiesewetter, A. Birk, F. Jung and H. Radtke, Effects of felodipine on the arterial blood pressure and fluidity of blood in patients with arterial hypertension WHO stage I, Clin. Hemorheol. 14 (1994), 355-367.
8. W. Koenig, M. Sund, E. Ernst, R. Hehr, L. Binner, J. Rosenthal and V. Hombach, Effects of felodipine ER and hydrochlorothiazide on blood rheology in essential hypertension-a randomized, double-blind, crossover study, J. Intern. Med. 229 (1991), 553-558.
9. P. Költinger, W. Langsteger, G. Pierer, P. Lind, G. Klima, F. Reisecker and O. Eber, Effect of metoprolol on microcirculation and blood viscoelasticity, Acta Med. Austriaca 18 (1991), 75-77.
10. P. Költinger, W. Langsteger, P. Lind, F. Reisecker and O. Eber, Modification of blood viscosity and elasticity. Principle therapeutic approach in relation to its pathophysiology, Fortschr. Med. 110 (1992), 105-107.
11. M. Konishi, M. Sakakura and N. Tsushima, Effects of ketanserin on microhemodynamics and hemorheology in patients with essential hypertension, Cardiovasc. Drugs Tlier. 4(1) (1990), 101-104.
12. M. Labios, M. Romero, F. Gabriel, E. Fuster, E. Tatay and R. Valles, The blood rheology of diruetics, Rev. Clin. Esp. 187 (1990), 158-161.
13. M. Labios, M. Martinez, A. Vaya, F. Gabriel, J. Sempere and J. Aznar, Fibrinogeno y agregaciön eritrocitaria en hipertensiön arterial esencial, Hipertensión 12 (1995), 142-146.
14. M. Leschke, M. Vogt, W. Motz and B.E. Strauer, Blood rheology as a contributing factor in reduced coronary reserve in systemic hypertension, Am. J. Cardiol. 65 (1990), 56G-59G.